| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |